老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Propanc Biopharma, Inc.

1.89
-0.0584-2.99%
成交量：13.57万
成交额：25.67万
市值：2,385.65万
市盈率：-0.04
高：2.06
开：1.98
低：1.80
收：1.95
52周最高：30.00
52周最低：0.0002
股本：1,261.18万
流通股本：340.45万
量比：0.51
换手率：3.99%
股息：- -
股息率：- -
每股收益(TTM):-51.7796
每股收益(LYR):-1.7983
净资产收益率：-767.20%
总资产收益率：-298.55%
市净率：1.32
市盈率(LYR):-1.05

数据加载中...

总览公司新闻公告
2020/11/03

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/11/03

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/14

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/10/01

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/08/13

SEC问询函

CORRESP [Cover] - Correspondence
2020/08/13

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/07/22

SEC问询函

CORRESP [Cover] - Correspondence
2020/07/17

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/07/16

SEC问询函

CORRESP [Cover] - Correspondence
2020/07/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/02

SEC问询函

CORRESP [Cover] - Correspondence
2020/06/26

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/06/26

SEC问询函

CORRESP [Cover] - Correspondence
2020/05/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/13

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/04/03

重要事件披露

8-K - Current report
2020/02/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/02/11

SEC问询函

CORRESP [Cover] - Correspondence
2020/01/24

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
更多